100% Rapid Rescreening for Quality Assurance in a Quality Control Program in a Public Health Cytologic Laboratory

Autor: Celso di Loreto, Neuza Kasumi Shirata, Luzia Setuko Yamamoto, Maria da Gloria Mattosinho de Castro Ferraz, Lai W. S. Shih, Sonia Maria Miranda Pereira, Rosemeire O. L. Rodrigues, Yuriko Ito Sakai, Wiliam M. Pirani, Miria Dall’ Agnol, Maria Lúcia Utagawa, Camilo Lelis Feres, Adhemar Longatto Filho
Přispěvatelé: Universidade do Minho
Rok vydání: 2005
Předmět:
medicine.medical_specialty
Histology
Quality Assurance
Health Care

Low-Grade Squamous Intraepithelial Lesions
Cytodiagnosis
Medicina Básica [Ciências Médicas]
Bethesda system
Uterine Cervical Neoplasms
Rapid rescreening
Cervical intraepithelial neoplasia
Sensitivity and Specificity
Pathology and Forensic Medicine
03 medical and health sciences
0302 clinical medicine
Cytology
Internal medicine
medicine
Humans
Mass Screening
Papanicolaou smear
Cervical Intraepithelial Neoplasia
Mass screening
Vaginal Smears
Gynecology
Cervical cancer
Medical Audit
Science & Technology
medicine.diagnostic_test
business.industry
Health care quality assurance
Quality control
Continuing education
General Medicine
Uterine Cervical Dysplasia
030224 pathology
medicine.disease
3. Good health
030220 oncology & carcinogenesis
Ciências Médicas::Medicina Básica
Public Health Practice
Female
Laboratories
business
Quality assurance
Brazil
Zdroj: Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
ISSN: 1938-2650
0001-5547
DOI: 10.1159/000326252
Popis: To verij5 the efficacy of the quality control (QC) program in a cytologic laboratwy with a rapid rescreening (RR) protocol. To verij5 the efficacy of the quality control (QC) program in a cytologic laboratwy with a rapid rescreening (RR) protocol.RR, according to the Turret RR method, of all samples initially screened as negative at the Laboratory of Cytology, Adolfo Lutz Institute, was performed. The slides were reviewed for 60 seconds. Suspect smears were fully checked by 2 reviewers to determine the final diagnoses. A total of 2954 sequential cytologic results were considered in this study. Of the 2954, 2568 (86.9%) were considered initially negative according to our internal QC, and these cases underwent RR. Also, 10% were randomly selected from these negative cases for full reviewing. The internal QC in our laboratory includes review of cases selected according to clinical and cytomorphologic criteria.Among the 2954 total cases, QC detected 386 (13%) atypias with final diagnoses reported according to The Bethesda System 2001 as follows: 82 (2.18%) low grade squamous intraepithelial lesions (LSILs), 35 (1.18%) high grade squamous intraepithelial lesions (HSILs), 2 (0.06%) squamous cell carcinomas, 105 (3.5%) atypical cells of undetermined significance (ASC-US), 4 (0.12%) atypical endocervical cells (AECs) and 158 (5.3%) unsatisfactory samples. RR of 2568 smears initially considered negative selected 194 (7.5%) slides. Of the 194, 146 (75.3%) were negative, 28 (14.4%) ASC-US, 5 (2.6%) AEC, 1 (0.5%) LSIL and 14 (7.2%) unsatisfactory. Full review of a 10% random fraction of the 2568 cases interpreted as negative did not detect lesions but did detect 5 (1.95%) unsatisfactory samples.Internal QC used in our laboratory based on clinical and cytomorphologic criteria to select cases for review proved to be an efficient method of detecting HSIL and cervical cancer. The consensus basis of this program strongly limits the false positive and false negative rates and also provides subjects with continuing education. One hundred percent RR is more efficient than 10% full reviewing in detecting cervical abnormalities.
Databáze: OpenAIRE